drug · antibody
patient view →faricimab
Marketedupdated 2mo agoby F. Hoffmann-La Roche Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 5 investigational indications.
indications
investigational
Diabetic Macular Edema
targets
Angiopoietin-2Vascular endothelial growth factor A, long form
all catalysts(5)
approval · 5
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that